Similar Items: Evaluation of small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 for their radiomodulatory effects in human breast cancer cell lines
- One year of breast cancer in Ibadan, Southwestern Nigeria: a histopathological review
- Novel treatment strategies for breast, lung and cervical cancer
- An investigation into the role of Serum amyloid A in breast cancer
- Chemotherapy naive breast cancer: a correlation study between BD Cytorich™ Red cell blocks and formalin- fixed paraffinembedded tissue blocks
- Treatment outcomes of young patients with invasive breast cancer treated radically at Groote Schuur Hospital from 2013-2017: A single centre study
- Extended cost effectiveness analysis of interventions for early detection, screening and breast cancer control: case studies of South Africa and Uganda
Author: Akudugu, John M.
- Assessment of point-of-care testing for prediction of aromatase inhibitor-associated side effects in obese postmenopausal breast cancer patients screened for cardiovascular risk factors
- Evaluation of BCL-2 and PARP-1 as potential therapeutic targets to radiosensitise lung cancer
- Radiosensitisation of low HER-2 expressing human breast cancer cell lines
- Evaluation of small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 for their radiomodulatory effects in human breast cancer cell lines
- Evaluation of the BCL-2, PI3K, PARP-1, and HSP90 pathways in breast, lung and glial cell lines for identification of candidate genes as therapeutic targets for overcoming radioresistance.
- Evaluation of the effect of low and intermediate frequency electromagnetic waves on radiosensitivity